CAS

179324-69-7

DESCRIPTION

Bortezomib is an anti-cancer medicine used to treat multiple myeloma and mantle cell lymphoma. ICROM manufactures Bortezomib under high containment, suitable for injectable preparations.

Interested in this API?

Contact us and one of our Account Managers will follow up with you as soon as possible.